STAB

Statera Biopharma Inc (STAB)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 7.14K
P/E Ratio
0.00
Revenue (TTM)
$ 3.69M
Volume
0
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
242.78

Technicals

50-Day MA
0.0001
200-Day MA
0.0002
52 Week High
0.0008
52 Week Low
0.0001

About STAB

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platf.

Employees
46
Headquarters
Fort Collins, CO
CEO
Dr. Blake Hawley D.V.M., M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg